Satoshi Ishii
Oita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease.
Journal: Molecular genetics and metabolism reports
Published: December 25, 2022
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.
Journal: Current issues in molecular biology
Published: May 13, 2021
Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease.
Journal: The Journal of biological chemistry
Published: January 15, 2020
Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: July 17, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: February 08, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 08, 2018
Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: June 28, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 06, 2017
A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis.
Journal: The Biochemical journal
Published: October 08, 2013
Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 12, 2013
Pharmacological chaperone therapy for Fabry disease.
Journal: Proceedings of the Japan Academy. Series B, Physical and biological sciences
Published: January 14, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026